Αρχική World News FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone... World News FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma Από Ogkologos - 7 Οκτωβρίου, 2026 443 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the EXCALIBER-RRMM study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Quitting Smoking Improves Survival in People with Lung Cancer 14 Σεπτεμβρίου, 2021 Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre... 2 Σεπτεμβρίου, 2020 Appendix Cancers Are Genetically Distinct from Other Gastrointestinal Cancers, Study Shows 12 Σεπτεμβρίου, 2018 Efficacy of Dabrafenib Plus Trametinib in First-Line Treatment for Children and... 11 Οκτωβρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Addressing the Barriers to Minority Participation in Cancer Clinical Trials Implementation of Molecular Tumour Board Portal Developed Under the Umbrella of... Los ensayos clínicos y las personas mayores, con Dr. Enrique Soto FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma